Is Rafarma Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Rafarma Pharmaceuticals Inc (RAFA) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Rafarma Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Rafarma Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Rafarma Pharmaceuticals Inc?

Muslim investors may consider investing in Rafarma Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Rafarma Pharmaceuticals Inc classified as HALAL?

Musaffa determines the Shariah status of Rafarma Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Rafarma Pharmaceuticals Inc updated?

The Shariah compliance status of Rafarma Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Rafarma Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Rafarma Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Rafarma Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

RAFA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 15, 2026

Report Source: 2025 3rd Quarter Report

Rafarma Pharmaceuticals Inc. Stock Analysis RAFA

United States N/A Nano Cap Report: Q3, 2025

Rafarma Pharmaceuticals, Inc. engages in the manufacture and marketing of pharmaceutical goods. The company is headquartered in Draper, Utah. The company went IPO on 2001-07-11. The firm is owned with a portfolio of companies that manufacture and distribute generic drugs, equipment and drugs for nuclear medicine, research on new drugs, as well as a complex of vivarium laboratories that develop high technology drugs in the biotechnology sector. The firm's subsidiaries include LLC MSCH Slavich, LLC Trading House Slavich and Slavich Noya Technologies LLC.

Key Statistics of Rafarma Pharmaceuticals Inc (RAFA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.04$0.06

Today's Open

$0.05

Volume

14.21K

P/E Ratio (TTM)

52 Week Range

$0.00$0.15

Market Cap

5.45M

Avg. Volume

17.87K

Dividend Yield

Financial Metrics & Statements of Rafarma Pharmaceuticals Inc (RAFA)

FAQ's for Rafarma Pharmaceuticals Inc (RAFA)

According to Musaffa’s Shariah screening methodology, Rafarma Pharmaceuticals Inc (RAFA) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.